Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin with neoadjuvant chemoradiation in rectal cancer
NCT03053544Phase 2Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Dec 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in rectal cancer, sponsored by Sunnybrook Health Sciences Centre. Started Dec 2016; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03053544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03053544.